Last updated: February 23, 2026
What is NDC 00480-3683?
NDC 00480-3683 corresponds to Fexofenadine Hydrochloride Tablets, 60 mg. It is an antihistamine used primarily for allergy relief, including hay fever and chronic idiopathic urticaria.
Market Size and Demand Drivers
Current Market Landscape
- The global antihistamine market was valued at approximately USD 6.5 billion in 2022.
- North America accounts for roughly 45% of the market, driven by high allergy prevalence and OTC availability.
- The US holds a dominant position within North America, with about USD 3 billion in sales for antihistamines in 2022.
Key Demand Factors
- Increasing allergy prevalence: an estimated 30% of adults and 40% of children worldwide suffer from allergic rhinitis.
- OTC availability: Availability of fexofenadine as a generic OTC product drives high volume sales.
- Prescriptions and generics: The drug's patent expiry in 2015 led to a surge in generic versions, intensifying price competition.
Competitive Landscape
- Major players include Mylan, Teva, Sandoz, and other generics manufacturers.
- Brand-name products such as Allegra (by Sanofi) hold a smaller share post-generic entry.
- The entry of multiple generics has compressed prices, especially in OTC markets.
Pricing Dynamics
Historical Price Trends
- Average wholesale price (AWP) for branded Allegra remained around USD 0.60 per tablet pre-patent expiry.
- Post-2015, generic tablets' prices dropped to approximately USD 0.20 per tablet, with some as low as USD 0.10 in bulk.
Current Retail and Wholesale Prices
| Price Trend |
Typical Cost per 60 mg Tablets |
Notes |
| Retail (OTC) |
USD 0.15 - USD 0.25 |
Due to high competition, OTC pricing stays low |
| Wholesale |
USD 0.10 - USD 0.20 |
Buyers often negotiate discounts, especially in bulk |
Price Projections
- In the next 1-2 years, prices are expected to remain stable or slightly decline due to market saturation.
- For niche markets or compounded formulations, premium pricing could persist.
- Emerging markets and direct-to-consumer sales may see prices as low as USD 0.08 per tablet, driven by local generic manufacturers.
Regulatory and Patent Landscape
Patent Status
- The original patent for Allegra expired globally by 2015.
- No current patents protect the marketed generic version.
- Regulatory barriers are minimal for generics in the US and Europe.
Regulatory Considerations
- FDA-approved generics account for over 85% of sales.
- Market entry costs are low, with generics typically approved via an ANDA (Abbreviated New Drug Application).
Future Market and Price Evolution
Potential Market Changes
- Growth in OTC channels due to COVID-19 pandemic normalized anti-allergy treatments.
- Increased patient awareness may sustain demand levels.
- Differentiation through formulation improvements (e.g., dissolvable tablets) could command slightly higher prices.
Price Outlook (2023-2027)
- If competition remains intense, prices could decrease marginally by 5-10%.
- Market consolidation or regulatory changes could influence pricing strategies.
- Regional price disparities may persist, with developing markets offering lower prices.
Key Takeaways
- The market for 60 mg fexofenadine tablets remains saturated with intense price competition.
- Wholesale prices are in the USD 0.10 - USD 0.20 range; OTC retail prices hover around USD 0.15.
- Future price decreases are likely, barring formulation innovations or regional regulatory shifts.
- The global allergy treatment market is robust, driven by rising allergy prevalence and OTC availability.
- Market entry costs are minimal due to patent expiry and a mature generic landscape.
FAQs
Q1: Will the price of NDC 00480-3683 increase in the future?
No, due to widespread generic competition and market saturation, prices are expected to stay flat or decline modestly.
Q2: How does regional regulation impact pricing?
Regions with fewer generic manufacturers or regulatory barriers may sustain slightly higher prices compared to highly competitive markets like the US.
Q3: Are there opportunities to differentiate this drug to command higher prices?
Yes, formulations that improve patient compliance or delivery (e.g., dissolvable or combo formulations) could support premium pricing.
Q4: What is the typical volume of sales for this medication?
In the US, annual OTC and prescription sales exceed 2 billion tablets, translating to a market value in hundreds of millions USD.
Q5: How do patent expiries influence current pricing?
Patent expiry in 2015 allowed multiple generics to enter, significantly deflating prices and increasing consumer accessibility.
References
[1] Grand View Research. (2022). Antihistamines Market Size, Share & Trends Analysis.
[2] IQVIA. (2022). US Prescription and OTC Market Data.
[3] U.S. Food & Drug Administration. (2022). ANDA Approvals and Patent Status.
[4] MarketWatch. (2023). Global Allergy Market Forecasts.
[5] Healthcare Pharma. (2022). Generic Drug Pricing Trends in North America.
